title: Chronic myelogenous leukemia presenting with bilateral optic disc neovascularization.
authors.affiliation: University of Iowa Hospitals & Clinics, Iowa City, Iowa. Electronic address: dalmeida@evolation-medical.com.
authors.forename: David R P
authors.initials: DR
authors.lastname: Almeida
authors.affiliation: University of Iowa Hospitals & Clinics, Iowa City, Iowa.
authors.forename: Eric K
authors.initials: EK
authors.lastname: Chin
authors.affiliation: University of Iowa Hospitals & Clinics, Iowa City, Iowa.
authors.forename: Lorna W
authors.initials: LW
authors.lastname: Grant
mesh_terms: D003131:Combined Modality Therapy; D000069439:Dasatinib; D005451:Fluorescein Angiography; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D017075:Laser Coagulation; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis* / Q000628:therapy; D007958:Leukocyte Count; D007964:Leukocytosis; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009898:Optic Disk / Q000098:blood supply*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D015861:Retinal Neovascularization / Q000175:diagnosis* / Q000628:therapy; D013844:Thiazoles / Q000627:therapeutic use; D014792:Visual Acuity; D014821:Vitrectomy
chemical_list: D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib